Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 31;22(1):301.
doi: 10.1186/s12951-024-02556-8.

M1 macrophage-derived exosomes promote intervertebral disc degeneration by enhancing nucleus pulposus cell senescence through LCN2/NF-κB signaling axis

Affiliations

M1 macrophage-derived exosomes promote intervertebral disc degeneration by enhancing nucleus pulposus cell senescence through LCN2/NF-κB signaling axis

Chunyang Fan et al. J Nanobiotechnology. .

Abstract

Intervertebral disc degeneration (IVDD) is the primary factor contributing to low back pain (LBP). Unlike elderly patients, many young IVDD patients usually have a history of trauma or long-term abnormal stress, which may lead to local inflammatory reaction causing by immune cells, and ultimately accelerates degeneration. Research has shown the significance of M1-type macrophages in IVDD; nevertheless, the precise mechanism and the route by which it influences the function of nucleus pulposus cell (NPC) remain unknown. Utilizing a rat acupuncture IVDD model and an NPC degeneration model induced by lipopolysaccharide (LPS), we investigated the function of M1 macrophage-derived exosomes (M1-Exos) in IVDD both in vivo and in vitro in this study. We found that M1-Exos enhanced LPS-induced NPC senescence, increased the number of SA-β-gal-positive cells, blocked the cell cycle, and promoted the activation of P21 and P53. M1-Exos derived from supernatant pretreated with the exosome inhibitor GW4869 reversed this result in vivo and in vitro. RNA-seq showed that Lipocalin2 (LCN2) was enriched in M1-Exos and targeted the NF-κB pathway. The quantity of SA-β-gal-positive cells was significantly reduced with the inhibition of LCN2, and the expression of P21 and P53 in NPCs was decreased. The same results were obtained in the acupuncture-induced IVDD model. In addition, inhibition of LCN2 promotes the expression of type II collagen (Col-2) and inhibits the expression of matrix metalloproteinase 13 (MMP13), thereby restoring the equilibrium of metabolism inside the extracellular matrix (ECM) in vitro and in vivo. In addition, the NF-κB pathway is crucial for regulating M1-Exo-mediated NPC senescence. After the addition of M1-Exos to LPS-treated NPCs, p-p65 activity was significantly activated, while si-LCN2 treatment significantly inhibited p-p65 activity. Therefore, this paper demonstrates that M1 macrophage-derived exosomes have the ability to deliver LCN2, which activates the NF-κB signaling pathway, and exacerbates IVDD by accelerating NPC senescence. This may shed new light on the mechanism of IVDD and bring a fresh approach to IVDD therapy.

Keywords: Cellular senescence; Exosome; Intervertebral disc degeneration; LCN2; Macrophage.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interest exists.

Figures

Fig. 1
Fig. 1
M1-dominated macrophage infiltration was present in IVDD. A Single cell expression matrix reduction of 8 degenerated intervertebral disc tissues. B Heat maps of specific high-expression genes in the top 5 of 15 cell subsets. C Relative expression levels of intervertebral disc cell markers in single cell expression matrix. D The relative expression levels of immune cell markers and macrophage markers in single cell expression matrix. E Final annotation results of single cell expression matrix. F UMAP dimension reduction results of macrophage reclassification. G The relative expression levels of M1 and M2 macrophage markers in the macrophage expression matrix
Fig. 2
Fig. 2
Extraction and identification of M1 macrophage-derived exosomes and their effects on IVDD. A Representative TEM images of M1-Exos and M0-Exos. Scale bars, 200 nm. B Representative chart of exosome size distribution measured by dynamic light scattering method. C WB analysis of Exos markers CD63 and TSG101 in the supernatant (Sup) and exosomes (Exos). D, E The expression and quantification of IVDD-specific proteins. F Representative fluorescence images of IVDD-specific markers. Scale bars, 50 μm. G The expression of IVDD-specific genes. ns: no significance, *P < 0.05, **P < 0.01
Fig. 3
Fig. 3
Targeted regulation of M1-Exos can affect the senescence of NPCs. A Representative fluorescence images of senescence markers after addition of M1-Exos. Scale bars, 50 μm. B SA-β-gal staining and quantitative analysis results after addition of M1-Exos. Scale bars, 100 μm. C The expression and quantification of senescence proteins after addition of M1-Exos. D Representative fluorescent images of senescence markers after GW4869 intervention. Scale bars, 50 μm. E SA-β-gal staining and quantitative analysis results after GW4869 intervention. Scale bars, 100 μm. F The expression and quantification of senescence proteins after GW4869 intervention. ns: no significance, *P < 0.05, **P < 0.01
Fig. 4
Fig. 4
Inhibition of M1 macrophage-derived exosomes can delay the senescence of nucleus pulposus cells in vivo. A X-ray examination of rat caudal at 1 week after surgery. B T2-weighted MRI scans of rat caudal at 1 week after surgery. C H&E and safranin-O staining of rat caudal IVD and histological grade. Scale bars, 1000 μm. D Representative fluorescent images of senescence markers after GW4869 intervention. Scale bars, 50 μm. E Representative fluorescent images of IVDD-specific markers after GW4869 intervention. Scale bars, 50 μm. ns: no significance, *P < 0.05, **P < 0.01
Fig. 5
Fig. 5
M1-Exos aggravates IVDD via LCN2. A Volcano plots of all differentially expressed genes (> 1.3 times) after M1-Exos and M0-Exos intervention with NPCs. B Heatmaps of all differentially expressed genes (> 1.3 times) after M1-Exos and M0-Exos intervention with NPCs. C The enriched KEGG pathways. D Representative fluorescent images of LCN2. Scale bars, 50 μm. E The expression and quantification of LCN2. F The mRNA levels of LCN2. ns: no significance, *P < 0.05, **P < 0.01
Fig. 6
Fig. 6
M1-Exos transport LCN2 promotes senescence of NPCs through NF-κB signaling pathway. A Representative fluorescence images of senescence markers after transfection with si-LCN2. Scale bars, 50 μm. B SA-β-gal staining and quantitative analysis results after transfection with si-LCN2. Scale bars, 100 μm. C The expression and quantification of senescence proteins after transfection with si-LCN2. D Representative fluorescent images of LCN2 after transfection with si-LCN2. Scale bars, 50 μm. E The expression and quantification of LCN2. F Representative fluorescence images of IVDD-specific markers after transfection with si-LCN2. Scale bars, 50 μm. G The expression and quantification of IVDD-specific proteins after transfection with si-LCN2. H The expression and quantification of NF-κB signaling pathway proteins after transfection with si-LCN2. ns: no significance, *P < 0.05, **P < 0.01
Fig. 7
Fig. 7
Inhibition of LCN2 can delay the senescence of nucleus pulposus cells in vivo. A X-ray examination of rat caudal at 1 week after surgery. B T2-weighted MRI scans of rat caudal at 1 week after surgery. C H&E and safranin-O staining of rat caudal IVD and histological grade. Scale bars, 1000 μm. D Representative fluorescent images of senescence markers after si-LCN2 intervention. Scale bars, 50 μm. E Representative fluorescent images of LCN2 after si-LCN2 intervention. Scale bars, 50 μm. F Representative fluorescent images of IVDD-specific markers after si-LCN2 intervention. Scale bars, 50 μm. ns: no significance, *P < 0.05, **P < 0.01
Fig. 8
Fig. 8
Schematic illustration of the mechanism related to LCN2 delivery by M1 macrophage-derived exosomes to promote nucleus pulposus cell senescence

Similar articles

Cited by

References

    1. Carapetis JR, Dadi AF. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global burden of disease study 2016. Lancet. 2017;390:1211–1259. doi: 10.1016/S0140-6736(17)32154-2. - DOI - PMC - PubMed
    1. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, Abdollahpour I. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7. - DOI - PMC - PubMed
    1. Francisco V, Pino J, González-Gay M, Lago F, Karppinen J, Tervonen O, Mobasheri A, Gualillo O. A new immunometabolic perspective of intervertebral disc degeneration. Nat Rev Rheumatol. 2022;18:47–60. doi: 10.1038/s41584-021-00713-z. - DOI - PubMed
    1. Ruiz-Fernández C, Francisco V, Pino J, Mera A, González-Gay MA, Gómez R, Lago F, Gualillo O. Molecular relationships among obesity, inflammation and intervertebral disc degeneration: are adipokines the common link? Int J Mol Sci. 2019;20:2030. doi: 10.3390/ijms20082030. - DOI - PMC - PubMed
    1. Karademir M, Eser O, Karavelioglu E. Adolescent lumbar disc herniation: Impact, diagnosis, and treatment. J Back Musculoskelet Rehabil. 2017;30:347–352. doi: 10.3233/BMR-160572. - DOI - PubMed